<DOC>
	<DOCNO>NCT00245544</DOCNO>
	<brief_summary>The purpose study test safety effect MK0759 relieve neuropathic pain experience patient postherpetic neuralgia ( PHN ) .</brief_summary>
	<brief_title>Safety Preliminary Efficacy MK0759 Postherpetic Neuralgia ( PHN ) ( 0759-004 )</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Neuralgia , Postherpetic</mesh_term>
	<criteria>Age 18 85 ; diagnosis postherpetic neuralgia pain persist least 6 month ; dissatisfy current regimen pain control ; able complete study questionnaire , patient diary , comply daily study medication Women childbearing potential ; history evidence condition , opinion investigator , may interfere study interpretation ( e.g. , diabetic neuropathy fibromyalgia ) pose undue risk undergo course medication require study ( e.g. , unstable heart disease , morbid obesity , kidney liver disease ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>